OraSure Technologies (OSUR) Competitors $3.08 +0.02 (+0.65%) As of 07/3/2025 03:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OSUR vs. STAA, CERS, UTMD, ANIK, WST, COO, ALGN, MMSI, HAE, and ICUIShould you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include STAAR Surgical (STAA), Cerus (CERS), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "health care supplies" industry. OraSure Technologies vs. Its Competitors STAAR Surgical Cerus Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical OraSure Technologies (NASDAQ:OSUR) and STAAR Surgical (NASDAQ:STAA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Which has better earnings & valuation, OSUR or STAA? OraSure Technologies has higher earnings, but lower revenue than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOraSure Technologies$185.83M1.24-$19.50M-$0.42-7.33STAAR Surgical$313.90M2.82-$20.21M-$1.44-12.40 Do analysts prefer OSUR or STAA? OraSure Technologies presently has a consensus target price of $3.00, indicating a potential downside of 2.60%. STAAR Surgical has a consensus target price of $24.63, indicating a potential upside of 37.96%. Given STAAR Surgical's higher probable upside, analysts clearly believe STAAR Surgical is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do insiders & institutionals believe in OSUR or STAA? 93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 3.9% of OraSure Technologies shares are held by company insiders. Comparatively, 1.0% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media prefer OSUR or STAA? In the previous week, STAAR Surgical had 4 more articles in the media than OraSure Technologies. MarketBeat recorded 4 mentions for STAAR Surgical and 0 mentions for OraSure Technologies. STAAR Surgical's average media sentiment score of 0.82 beat OraSure Technologies' score of 0.00 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Overall Sentiment OraSure Technologies Neutral STAAR Surgical Positive Which has more volatility and risk, OSUR or STAA? OraSure Technologies has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Is OSUR or STAA more profitable? OraSure Technologies has a net margin of -19.77% compared to STAAR Surgical's net margin of -25.46%. OraSure Technologies' return on equity of -5.86% beat STAAR Surgical's return on equity.Company Net Margins Return on Equity Return on Assets OraSure Technologies-19.77% -5.86% -5.20% STAAR Surgical -25.46%-10.59%-8.32% SummarySTAAR Surgical beats OraSure Technologies on 8 of the 15 factors compared between the two stocks. Get OraSure Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSUR vs. The Competition Export to ExcelMetricOraSure TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$230.38M$10.19B$5.49B$9.02BDividend YieldN/A2.09%5.38%4.09%P/E Ratio-7.3316.7427.4720.28Price / Sales1.2429.14408.30121.41Price / Cash78.8222.8436.6357.47Price / Book0.563.668.095.67Net Income-$19.50M$235.40M$3.17B$248.96M7 Day Performance2.33%2.15%2.82%3.30%1 Month Performance6.21%3.00%3.69%5.20%1 Year Performance-23.57%-10.21%35.42%21.37% OraSure Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSUROraSure Technologies1.0444 of 5 stars$3.08+0.7%$3.00-2.6%-23.6%$230.38M$185.83M-7.33840STAASTAAR Surgical4.1242 of 5 stars$16.68+2.1%$24.63+47.6%-58.6%$826.16M$313.90M-11.581,211CERSCerus3.4305 of 5 stars$1.34flat$3.50+161.2%-12.8%$256.15M$180.27M-13.40290News CoveragePositive NewsUTMDUtah Medical Products2.4093 of 5 stars$54.89+2.3%N/A-12.2%$178.28M$39.27M14.52180News CoveragePositive NewsANIKAnika Therapeutics3.7794 of 5 stars$10.92+3.1%$20.00+83.2%-55.6%$156.59M$119.91M-2.81300WSTWest Pharmaceutical Services4.7653 of 5 stars$217.05+0.6%$332.50+53.2%-31.0%$15.60B$2.89B34.0710,600COOCooper Companies3.4478 of 5 stars$69.52+0.1%$99.70+43.4%-14.6%$13.89B$3.99B33.7516,000High Trading VolumeALGNAlign Technology4.5479 of 5 stars$183.42+0.9%$241.25+31.5%-19.1%$13.30B$4.00B33.4120,945Positive NewsMMSIMerit Medical Systems4.377 of 5 stars$92.32+0.4%$109.11+18.2%+9.0%$5.46B$1.36B45.267,400News CoveragePositive NewsHAEHaemonetics4.8613 of 5 stars$72.15+1.5%$97.89+35.7%-8.7%$3.47B$1.36B21.803,023ICUIICU Medical4.5324 of 5 stars$128.07+0.3%$192.67+50.4%+14.8%$3.15B$2.38B-33.4415,000 Related Companies and Tools Related Companies STAAR Surgical Competitors Cerus Competitors Utah Medical Products Competitors Anika Therapeutics Competitors West Pharmaceutical Services Competitors Cooper Companies Competitors Align Technology Competitors Merit Medical Systems Competitors Haemonetics Competitors ICU Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSUR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OraSure Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
